Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.9600
+0.0078 (0.82%)
Jan 28, 2026, 12:06 PM EST - Market open
Immuron Employees
Immuron had 7 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$682,489
Profits / Employee
-$488,521
Market Cap
8.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 7 | 0 | - |
| Jun 30, 2024 | 7 | 1 | 16.67% |
| Jun 30, 2023 | 6 | 1 | 20.00% |
| Jun 30, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Aptevo Therapeutics | 37 |
| SeaStar Medical Holding | 19 |
| BioVie | 13 |
| Kiora Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
| MetaVia | 9 |
| Alzamend Neuro | 7 |
IMRN News
- 6 days ago - Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target - Accesswire
- 9 days ago - Immuron Reports Continued Sales Growth - GlobeNewsWire
- 3 months ago - Immuron IMM-529 IND approved by FDA - GlobeNewsWire
- 3 months ago - Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target - Newsfile Corp
- 3 months ago - Immuron Q1 FY26 YoY growth - GlobeNewsWire
- 4 months ago - Immuron Submits IMM-529 IND to FDA - GlobeNewsWire
- 4 months ago - Immuron Letter to Shareholders – Projects Update - GlobeNewsWire
- 5 months ago - Immuron partners with InvestorHub - GlobeNewsWire